Skip to content
Life Sciences Seed Founded 2022

Subsense

Developer of non-surgical brain-computer interfaces using biocompatible nanoparticles. Developer of non-surgical brain-computer interfaces using biocompatible nanoparticles. This technology facilitates the recording and stimulation of neural activity, offering potential applications in treating neurological disorders, enhancing human-machine interaction, and improving diagnostic capabilities. The system's…

📍 Covina, United States · Neurology,

Funding snapshot

Last roundSeed
Amount$10M
Date11 December 2025
Total raised$27M
Team size33

About

Developer of non-surgical brain-computer interfaces using biocompatible nanoparticles. Developer of non-surgical brain-computer interfaces using biocompatible nanoparticles. This technology facilitates the recording and stimulation of neural activity, offering potential applications in treating neurological disorders, enhancing human-machine interaction, and improving diagnostic capabilities. The system's non-invasive nature ensures a safer and more accessible approach compared to traditional methods. The company operates in the Life Sciences > Neurology, High Tech > Brain Computer Interface sector. Founded in 2022 and headquartered in Covina, United States and has raised $27.0 million in Seed funding. Key investors include Golden Falcon Capital.

Business model

Brain Computer Interface > Applications > Healthcare > Therapeutics,

Neurology > Medical Devices > Therapeutic Devices > Neurorehabilitation > Clinic Based > Functional Electrical Stimulation

Institutional investors

Golden Falcon Capital

Latest coverage

No articles yet.

Raising like Subsense?

Analyze your pitch deck before your next raise.

Analyze My Deck →